Atkinson, NH, United States of America

Catherine Rochford


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 61(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Catherine Rochford: Innovator in Cardiac Resuscitation Technology

Introduction: Catherine Rochford, an esteemed inventor based in Atkinson, NH, is recognized for her groundbreaking work in cardiac resuscitation technology. With her innovative mind, she has contributed significantly to the medical field through her patent that integrates advanced detection systems with defibrillation techniques.

Latest Patents: Catherine holds a single patent for an "Integrated Cardiac Resuscitation System with Ability to Detect Perfusion." This invention features a cardiac resuscitation apparatus that connects to either an automated external programmable defibrillator (AED) or a semi-automated external programmable defibrillator (SAED). The system employs an adhesive Doppler pad to detect a pulse signal from the patient, while defibrillation-monitoring pads capture the ECG signal. A sophisticated processor then integrates these signals to ascertain the suitability of shock therapy for the patient.

Career Highlights: Catherine Rochford is currently employed at Koninklijke Philips Corporation N.V., a global leader in healthcare technology. Her work centers on advancing medical devices that enhance patient care and improve emergency response outcomes. With her diligent efforts, she aims to enhance survival rates in critical situations.

Collaborations: Throughout her career, Catherine has collaborated with notable colleagues, including Joseph Ernest Rock and Michael Nakagawa. Their teamwork has fostered a unique environment of innovation, leading to significant advancements in cardiac care technology.

Conclusion: Catherine Rochford stands out as a pioneering inventor in the realm of cardiac resuscitation. Her patented technology showcases her commitment to improving emergency medical response and patient health outcomes. As she continues to innovate at Koninklijke Philips Corporation N.V., the impact of her work will undoubtedly extend to many lives in need of timely and effective cardiac interventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…